Overview
- The AMA and the University of Minnesota–hosted Vaccine Integrity Project will evaluate vaccine safety and effectiveness for influenza, COVID-19 and RSV ahead of the next season.
- Outputs will be evidence reviews for clinicians, state health officials and other decision-makers rather than formal vaccination recommendations.
- The process will use expert panels, monthly scientific meetings, systematic literature reviews, comparative analyses, public protocols, conflict-of-interest disclosures and philanthropic funding.
- Organizers said ACIP has effectively collapsed, while HHS rejected that claim as categorically false and reiterated that ACIP remains the nation’s vaccine advisory body.
- The move follows major federal policy changes and declining CDC trust, with a KFF poll showing trust falling from 85% in March 2020 to 47%, as groups like the AAP and ACOG chart independent guidance.